Stockreport

Press Release: Sanofi's rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Sanofi Winthrop Industrie Sanofi's rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease Designation based on positive data from a phase 2 s [Read more]